Meloxicam associated eosinophilic pneumonia

A. Karakatsani, A. Chroneou, N. G. Koulouris, J. Jordanoglou (Athens, Greece)

Source: Annual Congress 2001 - Rare and unusual diseases or problems
Session: Rare and unusual diseases or problems
Session type: Thematic Poster Session
Number: 1520
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Karakatsani, A. Chroneou, N. G. Koulouris, J. Jordanoglou (Athens, Greece). Meloxicam associated eosinophilic pneumonia. Eur Respir J 2001; 16: Suppl. 31, 1520

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Eosinophilic pneumonia associated with pirfenidone therapy
Source: Eur Respir J 2016; 48: 1240-1242
Year: 2016


Clinical implication of interleukin-33 in acute eosinophilic pneumonia compared with chronic eosinophilic pneumonia
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011

Fibrosing cases of chronic eosinophilic pneumonia
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020

Drug induced eosinophilic pneumonia
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008


Idiopathic acute and chronic eosinophilic pneumonia
Source: Annual Congress 2009 - Update on eosinophilic lung diseases
Year: 2009


Chronic eosinophilic pneumonia with mucous plugs in a child
Source: Annual Congress 2010 - Paediatric respiratory infection, inflammation and immunology
Year: 2010

Apoptotic response of eosinophils in chronic eosinophilic pneumonia
Source: Eur Respir J 2001; 17: 190-194
Year: 2001



Acute eosinophilic pneumonia due to heroin inhalation
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018

Manifestation of idiopathic chronic eosinophilic pneumonia
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009


Recurrent eosinophilic pneumonia in an asthmatic patient treated with sequential montelukast/zafirlukast after corticosteroid withdrawal
Source: Eur Respir J 2002; 20: Suppl. 38, 52s
Year: 2002

Simvastatin in the treatment of eosinophilic asthma
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


Idiopathic eosinophilic pneumonias
Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases
Year: 2008

Idiopathic eosinophilic pneumonias
Source: Eur Respir Mon 2011; 54: 118-139
Year: 2011


Benralizumab for severe asthma associated with extra-airway eosinophilic diseases
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020


Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019

Diffuse idiopathic pulmonary neuroendocrine hyperplasia, chronic eosinophilic pneumonia, and asthma
Source: Eur Respir J 2009; 34: 1489-1492
Year: 2009


Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other?
Source: Eur Respir J 2003; 22: 8-13
Year: 2003



Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia
Source: Eur Respir J 2015; 45: 1624-1631
Year: 2015



Nonspecific interstitial pneumonia - NSIP
Source: Respipedia Article
Year: 2015

Solely an eosinophilic pneumonia or something more?
Source: Virtual Congress 2020 – Thoracic oncology
Year: 2020